Literature DB >> 12667057

Interdependence of backbone flexibility, residue conservation, and enzyme function: a case study on beta1,4-galactosyltransferase-I.

K Gunasekaran1, Buyong Ma, B Ramakrishnan, Pradman K Qasba, Ruth Nussinov.   

Abstract

Beta1,4-galactosyltransferase-I (beta4Gal-T1) catalyzes the transfer of a galactose from UDP-galactose to N-acetylglucosamine. A recent crystal structure determination of the substrate-bound enzyme reveals a large conformational change, which creates binding sites for the oligosaccharide and alpha-lactalbumin, when compared to the ligand-free structure. The conformational changes take place in a 21-residue-long loop (I345-H365) and in a smaller loop containing a tryptophan residue (W314) flanked by glycines (Y311-G316; Trp loop). A series of molecular dynamics simulations carried out with an implicit solvent model and with explicit water successfully identify flexibility in the two loops and in another interacting loop. These observations are confirmed by limited proteolysis experiments that reveal an intrinsic flexibility of the long loop. The multiple simulation runs starting with the substrate-free structure show that the long loop moves toward its conformation in the ligand-bound structure; however, it gets stabilized in an intermediate position. The Trp loop moves in the opposite direction to that of the long loop, making contacts with residues in the long loop. Remarkably, when the Trp loop is restrained in its starting conformation, no large conformational change takes place in the long loop, indicating residue communication of flexibility. Sequence and structural analysis of the beta4Gal-T1 family with 37 known sequences reveals that in contrast to the unconserved long loop, which undergoes a much larger conformational change, the Trp loop including the glycines is highly conserved. These observations lead us to propose a new functional mechanism that may be conserved by evolution to perform a variety of functions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667057     DOI: 10.1021/bi034046r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Crystal structures of β-1,4-galactosyltransferase 7 enzyme reveal conformational changes and substrate binding.

Authors:  Yuko Tsutsui; Boopathy Ramakrishnan; Pradman K Qasba
Journal:  J Biol Chem       Date:  2013-09-19       Impact factor: 5.157

2.  UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree.

Authors:  Jayalakshmi Raman; Yu Guan; Cynthia L Perrine; Thomas A Gerken; Lawrence A Tabak
Journal:  Glycobiology       Date:  2011-12-20       Impact factor: 4.313

3.  UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase--a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme.

Authors:  Inka Brockhausen; Melinda Benn; Shridhar Bhat; Sandra Marone; John G Riley; Pedro Montoya-Peleaz; Jason Z Vlahakis; Hans Paulsen; John S Schutzbach; Walter A Szarek
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

4.  Multiple glycines in TCR alpha-chains determine clonally diverse nature of human T cell memory to influenza A virus.

Authors:  Yuri N Naumov; Elena N Naumova; Maryam B Yassai; Kalyani Kota; Raymond M Welsh; Liisa K Selin
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

5.  Substrate-induced conformational changes and dynamics of UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase-2.

Authors:  A L Milac; N V Buchete; T A Fritz; G Hummer; L A Tabak
Journal:  J Mol Biol       Date:  2007-08-21       Impact factor: 5.469

Review 6.  Structure and function of beta -1,4-galactosyltransferase.

Authors:  Pradman K Qasba; Boopathy Ramakrishnan; Elizabeth Boeggeman
Journal:  Curr Drug Targets       Date:  2008-04       Impact factor: 3.465

7.  The dimeric structure of wild-type human glycosyltransferase B4GalT1.

Authors:  Deborah Harrus; Fawzi Khoder-Agha; Miika Peltoniemi; Antti Hassinen; Lloyd Ruddock; Sakari Kellokumpu; Tuomo Glumoff
Journal:  PLoS One       Date:  2018-10-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.